Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from 4DMedical Ltd ( (AU:4DX) ) is now available.
4DMedical Limited has announced its upcoming Annual General Meeting (AGM) scheduled for 30 October 2025, where an election of directors will take place. The company is inviting nominations for director positions, with a deadline of 11 September 2025. This AGM is a significant event for 4DMedical as it continues to solidify its leadership and strategic direction in the medical imaging industry. The meeting will provide an opportunity for stakeholders to engage with the company’s ongoing advancements and future plans, reinforcing its commitment to revolutionizing respiratory care.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$1.05 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Limited is a global medical technology company specializing in advanced imaging and artificial intelligence for respiratory care. The company offers a range of software solutions, including the FDA-cleared XV Lung Ventilation Analysis Software, CT LVAS, and CT:VQ, which enhance cardiothoracic imaging by integrating ventilation and perfusion analysis. Delivered through a Software-as-a-Service model, these solutions improve physician productivity and patient care by integrating into existing hospital infrastructure. The company’s acquisition of Imbio in 2023 has further advanced its AI capabilities, pushing the boundaries of medical imaging for respiratory disease treatment worldwide.
Average Trading Volume: 2,185,322
Technical Sentiment Signal: Buy
Current Market Cap: A$360.8M
For a thorough assessment of 4DX stock, go to TipRanks’ Stock Analysis page.